Aureobasidium.org

patent 2023

Bio-healing agent – Taiwan (Taiwan Patent No. I364284)

Iwai A., Uchiyama H. · Taiwan Intellectual Property Office
Research Archive
TL;DR — Key Findings
  • Taiwan patent (No. I364) protects AP β-glucan as bio-healing agent.
  • Taiwan IP coverage reflects Asian market expansion strategy for AP-glucan products.
  • Regional patent protection facilitates AP-glucan product commercialization across Asia.

Abstract

Bio-healing agent – Taiwan (Taiwan Patent No. I364284)

Patent Details

Country of RegistrationTaiwan

Patent No.Invention No. I364284Registration DateMay 21, 2012

Currently, in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been recognized to reduce the side effects of anticancer drugs and to promote the healing of erythema caused by burn wounds.Furthermore, in Taiwan, the combination of Aureobasidium culture solution and EF lactobacilli was also registered to improve the pathogenesis of leukemia.

Summary

Summary

Patent Overview

Taiwan Patent No. I364284 protects Aureobasidium pullulans-derived β-glucan as a bio-healing agent in Taiwan. This patent covers specific formulations and therapeutic methods using N-163 strain β-glucan to accelerate biological healing, including immune activation and tissue repair.

Significance

This Taiwanese patent is part of the Asian intellectual property portfolio for Aureobasidium pullulans N-163 β-glucan bio-healing applications, alongside the China (ZL200780040329.9) and Hong Kong (HK1136492) regional equivalents.

Citation

Iwai A., Uchiyama H.. Bio-healing agent – Taiwan (Taiwan Patent No. I364284). Taiwan Intellectual Property Office. 2023.

Study Details
Study Type
patent
Published
2023
Journal
Taiwan Intellectual Property Office
Authors
Iwai A., Uchiyama H.
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.